Podcast

Bill Kapogiannis, MD, on Disparities Among Youth With HIV in the Care Continuum

03/27/2020

 

In this podcast, Bill Kapogiannis, MD, discusses the multi-Federal agency SMILE Collaborative (Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of HIV-infected youth), which was an analysis of adolescents and young adults in the HIV care continuum in urban parts of the United States.

Additional Resources:

  • Kapogiannis B, Koenig LJ, Jiahong X, et al; the Adolescent Medicine Trials Network for HIV/AIDS Interventions. The HIV continuum of care for adolescents and young adults attending 13 urban US HIV care centers of the NICHD-ATN-CDC-HRSA SMILE Collaborative [published online January 28, 2020]. JAIDS J Acquir Immune Defic Syndr. doi:10.1097/QAI.0000000000002308.
  • Ending the HIV Epidemic: A Plan for America. Centers for Disease Control and Prevention. February 3, 2020. https://www.cdc.gov/endhiv/index.html.
  • Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN). Eunice Kennedy Shriver National Institute of Child Health and Human Development. June 13, 2019. https://www.nichd.nih.gov/research/supported/atn.
  • Fortenberry JD, Koenig LJ, Kapogiannis BG, Jeffries CL, Ellen JM, Wilson CM. Implementation of an integrated approach to the National HIV/AIDS Strategy for Improving Human Immunodeficiency Virus Care for Youths. JAMA Pediatr. 2017;171(7):687-693. https://doi.org/10.1001/jamapediatrics.2017.0454.
  • ATN Request for Proposals (RFP): Research Aimed at Ending the HIV Epidemic: A Plan for America. Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN). January 28, 2020. https://atnweb.org/atnweb/ending-the-hiv-epidemic-request-for-proposals. 

 

Bill Kapogiannis, MD, is a physician scientist and medical officer in the Maternal and Pediatric Infectious Disease Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the NIH in Bethesda, Maryland.

Related Content

Multiple Sclerosis
Multiple Sclerosis
Ilya Kister, MD, on the Risks of Stopping MS Disease-Modifying Therapies
11/14/2018
Ilya Kister, MD, from NYU Langone Health in New York City, discusses his research into the predictors of multiple sclerosis relapse and disability progression in patients who stop disease-modifying...
11/14/2018
Critical Care
Critical Care
The Evolving Critical Care Workforce Crisis: Women Leaders in Critical Care, Ep. 2
12/24/2020
Moderator Jaspal Singh, MD, MHA, MHS, interviews Meeta Kerlin, MD, MSCE, and Sue Stempek, PA-C, about the critical care workforce crisis, how the COVID-19 pandemic affected this crisis, and how being a...
12/24/2020
Psychiatry
Psychiatry
Robert S. Laitman, MD, Schizophrenia and the Use of Clozapine
02/06/2018
Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA, discusses schizophrenia and why clozapine is underutilized.
02/06/2018
Irritable Bowel Syndrome
Irritable Bowel Syndrome
William D. Chey, MD, on Dietary Strategies in IBS: Looking Beyond the Elimination Phase
07/08/2019
William D. Chey, MD, from Michigan Medicine, highlights the 3 phases of a low FODMAP diet in the treatment of IBS and the importance of moving a patient from the elimination phase to the reintroduction...
07/08/2019
Multiple Sclerosis
Multiple Sclerosis
Patricia K. Coyle, MD, on Progressive Multiple Sclerosis
07/23/2020
In this podcast, Dr Coyle reviews the diagnosis and clinical course of progressive multiple sclerosis (MS), pearls for distinguishing it from its differential diagnosis, and the importance of...
07/23/2020